Home
Conditions
Diabetes Mellitus, Type 2

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

7,974 public trials 716 recruiting studies

Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

Efficacy of Pioglitazone on Bone Metabolism in Postmenopausal Women With Impaired Fasting Glucose.

NCT00708175

Conditions: Bone Metabolism, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations: Greenbrae, California, United States

Los Banos, California, United States

San Diego, California, United States

Walnut Creek, California, United States

View all 34 locations

View Trial Details

Completed

Study of Alogliptin Combined With Sulfonylurea in Subjects With Type 2 Diabetes Mellitus.

NCT00286468

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidemias, +5 more
Locations: Birmingham, Alabama, United States

Peoria, Arizona, United States

Phoenix, Arizona, United States

Anaheim, California, United States

View all 68 locations

View Trial Details

Completed

Long-term Safety Study of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan

NCT01263509

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Not specified

View Trial Details

Completed

Long-term Safety Study of Alogliptin Used in Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan

NCT01318122

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Not specified

View Trial Details

Completed

Efficacy and Safety of Alogliptin in Subjects With Type 2 Diabetes

NCT00286455

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidemias, +5 more
Locations: Birmingham, Alabama, United States

Peoria, Arizona, United States

Phoenix, Arizona, United States

Anaheim, California, United States

View all 67 locations

View Trial Details

Completed

Safety and Efficacy Study of Alogliptin on Glycemic Control in Subjects With Type 2 Diabetes.

NCT00755846

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Efficacy and Safety of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan

NCT01263483

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Not specified

View Trial Details

Completed

Efficacy and Safety of Alogliptin Used Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan

NCT01318070

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Not specified

View Trial Details

Completed

Efficacy and Safety of Alogliptin Used in Combination With Sulfonylurea in Participants With Type 2 Diabetes in Japan

NCT01318083

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Not specified

View Trial Details

Completed

Safety, Tolerability and Activity Study of Multiple Doses of ISIS-SGLT2Rx in Healthy Volunteers

NCT00836225

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Center for Human Drug Research Leiden, Netherlands

View Trial Details

Diabetes Mellitus, Type 2

Diabetes Mellitus, Type 2 trial results

Related conditions